AzTrials
AzTrials

Hip FracturesHEMIUNIBIPOLNCT00746876

Unipolar or Bipolar Hemiarthroplasty in the Treatment of Displaced Femoral Neck Fractures.

A study testing Unipolar hip hemiarthroplasty and Bipolar hip hemiarthroplasty in people with Hip Fractures, run by Sykehuset Asker og Baerum at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hemiarthroplasty of the hip is standard treatment of femoral neck fractures (hip fractures). Hemiarthroplasty means replacing the hip joint with a metal prosthesis. Unipolar prostheses has a one-piece design where the hip movement occurs between the prosthesis and the acetabulum (hip socket). Read more about this study

Who is it for?
Ages 70 years and older
Conditions the study is for
Hip Fractures
What is being tested?
Unipolar hip hemiarthroplasty and Bipolar hip hemiarthroplasty
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28 participants
Where
1 siteNorway
Study dates
Sep 2009to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Displaced femoral neck fracture
  • 70 years or older
  • Ambulatory status: No walking aids
  • No mental illness or impaired cognitive function

Who cannot join

  • Pathological fracture (malignant disease)
  • Ongoing systemic or local infection
  • Radiologically presence of acetabular wear (osteoarthrosis)

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Asker and Baerum Hospital

    Baerum, Rud, 1309

Other trials in Norway

About this study

Official title: Unipolar or Bipolar Hemiarthroplasty in the Treatment of Displaced Femoral Neck Fractures. A Randomized Trial of RSA Measurements of Acetabular Wear.

Hemiarthroplasty of the hip is standard treatment of femoral neck fractures (hip fractures). Hemiarthroplasty means replacing the hip joint with a metal prosthesis. Unipolar prostheses has a one-piece design where the hip movement occurs between the prosthesis and the acetabulum (hip socket). A bipolar prosthesis has an additional artificial joint between the two components of the prosthesis. Both treatments are clinically proven and common around the world. No clinical trial has proven benefits of one or the other prosthesis design. The investigators want to measure the differences in acetabular wear using these two prostheses, using radiostereometric measurements.

Read the detailed description

Patients 70 years or older presenting to our hospital with an acute femoral neck fracture are eligible for inclusion. 15 patients in each group will be recruited. One group receives a unipolar hemiarthroplasty and 15 receives a bipolar arthroplasty. Tantalum markers are placed around the acetabulum during surgery. Follow-up intervals are at 3, 12 and 24 months with radiostereometric evaluation (radiographs) and clinical evaluation.

Conditions
Hip Fractures
Being tested
Unipolar hip hemiarthroplasty, Bipolar hip hemiarthroplasty
Keywords
Hip, Fracture, Femoral neck, Hemiarthroplasty, Bipolar, Unipolar, Displaced femoral neck fractures
Medical subject headings
Hip Fractures, Fractures, Bone

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Unipolar hip hemiarthroplastyDevice

    Also called Modular Cathcart Unipolar, DePuy/Johnson and Johnson

    Unipolar hip hemiarthroplasty for the treatment of femoral neck fractures

  • Bipolar hip hemiarthroplastyDevice

    Also called Celf-Centering Bipolar, DePuy/Johnson and Johnson

    Bipolar hip hemiarthroplasty for the treatment of femoral neck fractures

Study groups in NCT00746876
Study groupRoleWhat they receive
UnipolarActive comparator15 patients randomized for treatment with a unipolar hip hemiarthroplasty
Receives: Device: Unipolar hip hemiarthroplasty
BipolarActive comparator15 patients randomized for treatment with a bipolar hip hemiarthroplasty
Receives: Device: Bipolar hip hemiarthroplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acetabular wear measured with radiostereometry

    Measured: 24 months

Secondary outcomes (2)
  1. Harris hip score

    Measured: 24 months

  2. Health-related quality of life (eq-5d)

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Sep 2008 (estimated)
  2. Study startSep 2009
  3. Primary completionDec 2012
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
28 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00746876
Sponsor's protocol ID
HEMI-UNI-BIPOL
Acronym
HEMIUNIBIPOL
Status last verified
Apr 2016
First submitted
3 Sep 2008
Last updated
19 Apr 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Unipolar hip hemiarthroplasty and Bipolar hip hemiarthroplasty in people with Hip Fractures, run by Sykehuset Asker og Baerum at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Apr 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acetabular wear measured with radiostereometry (time frame: 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Apr 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in